サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1568085

DNAマイクロアレイの世界市場

DNA Microarrays

出版日
ページ情報
英文 234 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.57円
DNAマイクロアレイの世界市場
出版日: 2024年10月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 234 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

DNAマイクロアレイの世界市場は2030年までに35億米ドルに達する見込み

2023年に21億米ドルと推定されるDNAマイクロアレイの世界市場は、2023年から2030年にかけてCAGR 7.4%で成長し、2030年には35億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるオリゴヌクレオチドマイクロアレイは、CAGR 7.3%を記録し、分析期間終了時には26億米ドルに達すると予測されています。補完マイクロアレイ分野の成長率は、分析期間中CAGR 8.2%と推定されます。

米国市場は5億6,220万米ドルと推定、中国はCAGR7.2%で成長すると予測

米国のDNAマイクロアレイ市場は、2023年に5億6,220万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを7.2%として、2030年までに5億6,310万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.8%と6.3%と予測されています。欧州では、ドイツがCAGR 5.9%で成長すると予測されています。

世界のDNAマイクロアレイ市場- 主要動向と促進要因のまとめ

DNAマイクロアレイはゲノム調査にどのような革命をもたらしているか？

DNAマイクロアレイは、ゲノミクスにおいてますます重要な役割を果たすようになってきており、研究者は何千もの遺伝子の遺伝子発現パターンや遺伝的変異を同時に解析できるようになってきています。これらのデバイスは、固体表面に付着したDNAプローブの顕微鏡的スポットから構成されており、疾病診断、医薬品開発、個別化医療を含む様々なアプリケーションにおいて、遺伝子配列のハイスループット解析を可能にしています。がん研究においては、変異や遺伝子発現プロファイルの同定に使用され、腫瘍の分類や潜在的な治療経路に関する洞察を提供しています。さらに、この技術は遺伝性疾患の研究においても不可欠なツールとなっており、科学者が遺伝子と環境の相互作用や複雑な疾患メカニズムを理解するのに役立っています。精密医療への要求が高まり続ける中、DNAマイクロアレイはゲノム研究の礎石となりつつあり、より迅速かつ正確で大規模な遺伝子解析を促進しています。

どのような技術の進歩がDNAマイクロアレイの進化を促進しているのでしょうか？

技術革新は、DNAマイクロアレイの開発と効率性を大きく形成し、様々なアプリケーションに対してより正確でスケーラブルなものにしています。マイクロアレイ作製技術の進歩により、これらのデバイスの解像度と感度が向上し、研究者はより小さなサンプルをより正確に分析できるようになりました。蛍光ベースのアッセイのような標識・検出法の革新は、低存在遺伝子発現の検出能力を向上させました。さらに、バイオインフォマティクスツールの統合により、DNAマイクロアレイによって生成された大規模なデータセットの管理、解釈、視覚化が容易になり、研究者は複雑なデータから意味のある生物学的洞察を導き出すことができるようになった。さらに、マルチプレキシング技術の使用により、複数のバイオマーカーの同時検出が可能となり、DNAマイクロアレイは診断学や医薬品開発にとって非常に貴重なツールとなりました。これらの技術が進化し続ける中、DNAマイクロアレイがコスト効率と時間効率の高い方法で高解像度の遺伝子データを提供できることが、多様な研究分野での採用をさらに後押ししています。

消費者と産業界の行動はDNAマイクロアレイの需要にどのような影響を与えていますか？

消費者や業界の行動、特に個別化医療や標的治療への注目の高まりが、臨床や研究現場におけるDNAマイクロアレイの需要を促進しています。患者は自分の遺伝子プロファイルに合わせた治療を求めるようになっており、そのため遺伝的素因を特定し、治療方針の決定を導くゲノムツールに対する需要が高まっています。製薬業界では、DNAマイクロアレイは創薬や薬剤開発、特に薬剤ターゲットの同定や薬剤の有効性と安全性の評価において幅広く利用されています。農業バイオテクノロジー分野でも、作物形質の強化、育種プログラムの最適化、食糧安全保障のためにDNAマイクロアレイが採用されています。さらに、消費者直接遺伝子検査の台頭により、個人の遺伝的健康に対する意識が高まり、遺伝子研究や診断への関心が高まっています。このような消費者と産業界の行動の変化は、ゲノミクス主導の意思決定に重要なデータを提供するDNAマイクロアレイの採用を大きく後押ししています。

DNAマイクロアレイ市場の成長を促進する要因とは？

DNAマイクロアレイ市場の成長は、技術の進歩、最終用途の拡大、消費者行動の進化に関連するいくつかの要因によって牽引されています。主な促進要因のひとつは、遺伝子情報を利用してカスタマイズされた治療や治療を開発する個別化医療におけるDNAマイクロアレイの採用が増加していることです。マイクロアレイの解像度や感度の向上、バイオインフォマティクスの統合といった技術革新は、大規模なゲノム研究のためにこの技術をより利用しやすく効率的にすることで、市場をさらに押し上げています。がん研究、創薬、農業バイオテクノロジーなどの最終用途は、これらの分野で詳細な遺伝子解析の必要性が高まるにつれて拡大しています。さらに、消費者直接遺伝子検査サービスの台頭により、消費者ゲノムへの関心が高まっており、臨床および商業アプリケーションの両方でDNAマイクロアレイの需要を押し上げています。このような複合的な要因が、ゲノミクス研究への投資の増加とともに、DNAマイクロアレイ技術の世界の急成長と採用を後押ししています。

調査対象企業の例（全45件）

  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Arrayjet
  • BioCat GmbH
  • Bio-Rad Laboratories, Inc.
  • DNA Chip Research, Inc.
  • Eurofins Genomics Germany GmbH
  • evonetix
  • Illumina, Inc.
  • LC Sciences LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP24449

Global DNA Microarrays Market to Reach US$3.5 Billion by 2030

The global market for DNA Microarrays estimated at US$2.1 Billion in the year 2023, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Oligonucleotide Microarrays, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Complementary Microarrays segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$562.2 Million While China is Forecast to Grow at 7.2% CAGR

The DNA Microarrays market in the U.S. is estimated at US$562.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$563.1 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global DNA Microarrays Market - Key Trends & Drivers Summarized

How Are DNA Microarrays Revolutionizing Genomic Research?

DNA microarrays are playing an increasingly pivotal role in genomics, enabling researchers to analyze gene expression patterns and genetic variations across thousands of genes simultaneously. These devices consist of microscopic spots of DNA probes attached to a solid surface, allowing for the high-throughput analysis of gene sequences in various applications, including disease diagnostics, drug development, and personalized medicine. In cancer research, DNA microarrays are used to identify mutations and gene expression profiles, providing insights into tumor classification and potential treatment pathways. Furthermore, the technology has become an essential tool in the study of genetic disorders, helping scientists understand gene-environment interactions and complex disease mechanisms. As the demand for precision medicine continues to rise, DNA microarrays are becoming a cornerstone in genomics research, facilitating faster, more accurate, and large-scale genetic analysis.

What Technological Advancements Are Driving the Evolution of DNA Microarrays?

Technological innovations are significantly shaping the development and efficiency of DNA microarrays, making them more precise and scalable for a variety of applications. Advancements in microarray fabrication techniques have improved the resolution and sensitivity of these devices, allowing researchers to analyze smaller samples with greater accuracy. Innovations in labeling and detection methods, such as fluorescence-based assays, have enhanced the ability to detect even low-abundance gene expressions. Moreover, the integration of bioinformatics tools has made it easier to manage, interpret, and visualize large datasets generated by DNA microarrays, enabling researchers to derive meaningful biological insights from complex data. Additionally, the use of multiplexing technologies has allowed for the simultaneous detection of multiple biomarkers, making DNA microarrays an invaluable tool for diagnostics and drug development. As these technologies continue to evolve, the capability of DNA microarrays to provide high-resolution genetic data in a cost-effective and time-efficient manner is further driving their adoption across diverse research fields.

How Is Consumer and Industry Behavior Influencing the Demand for DNA Microarrays?

Consumer and industry behavior, particularly the increasing focus on personalized medicine and targeted therapies, is driving the demand for DNA microarrays in clinical and research settings. Patients are increasingly seeking treatments tailored to their genetic profiles, which has led to greater demand for genomic tools that can identify genetic predispositions and guide therapeutic decisions. In the pharmaceutical industry, DNA microarrays are being used extensively in drug discovery and development, particularly in the identification of drug targets and the assessment of drug efficacy and safety. The agricultural biotechnology sector is also adopting DNA microarrays to enhance crop traits, optimize breeding programs, and ensure food security. Additionally, the rise of direct-to-consumer genetic testing has made individuals more aware of their genetic health, spurring interest in genetic research and diagnostics. This shift in consumer and industry behavior is significantly boosting the adoption of DNA microarrays, as they provide critical data for genomics-driven decision-making.

What Factors Are Driving Growth in the DNA Microarrays Market?

The growth in the DNA microarrays market is driven by several factors related to technological advancements, expanding end-use applications, and evolving consumer behavior. One of the primary drivers is the increasing adoption of DNA microarrays in personalized medicine, where genetic information is used to develop customized treatments and therapies. Technological innovations, such as improvements in microarray resolution, sensitivity, and bioinformatics integration, are further propelling the market by making the technology more accessible and efficient for large-scale genomic studies. End-use applications in cancer research, drug discovery, and agricultural biotechnology are expanding as the need for detailed genetic analysis grows across these sectors. Additionally, the growing interest in consumer genomics, driven by the rise of direct-to-consumer genetic testing services, is boosting the demand for DNA microarrays in both clinical and commercial applications. These combined factors, along with increasing investment in genomics research, are driving the rapid growth and adoption of DNA microarray technology worldwide.

Select Competitors (Total 45 Featured) -

  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Arrayjet
  • BioCat GmbH
  • Bio-Rad Laboratories, Inc.
  • DNA Chip Research, Inc.
  • Eurofins Genomics Germany GmbH
  • evonetix
  • Illumina, Inc.
  • LC Sciences LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • DNA Microarrays - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Medicine and Genomic Research Spurs Growth in DNA Microarrays Market
    • Technological Advancements in High-Throughput Screening Strengthen Business Case for DNA Microarrays in Precision Medicine
    • Increasing Adoption of DNA Microarrays in Cancer Research Expands Market for Advanced Genetic Testing
    • Growing Use of DNA Microarrays in Drug Discovery and Development Drives Demand in Pharmaceutical Sector
    • Expansion of Genomic Studies for Complex Diseases Propels Adoption of DNA Microarray Technology
    • Rising Interest in Gene Expression Profiling and Biomarker Discovery Creates New Opportunities in Research
    • Advancements in Bioinformatics Tools and Data Analysis Solutions Strengthen the Utility of DNA Microarrays
    • Increasing Use of DNA Microarrays in Agriculture and Animal Genomics Expands Non-Clinical Applications
    • Growing Focus on Early Disease Detection and Diagnostics Drives Demand for DNA Microarray-Based Tests
    • Technological Integration of Next-Generation Sequencing with DNA Microarrays Enhances Performance and Flexibility
    • Rising Use of DNA Microarrays in Pathogen Detection and Infection Monitoring Expands Healthcare Applications
    • Expansion of Consumer Genomics and Direct-to-Consumer Genetic Testing Fuels Growth in DNA Microarrays Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA Microarrays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oligonucleotide Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oligonucleotide Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Oligonucleotide Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Complementary Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Complementary Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Complementary Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Microarray Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Microarray Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Microarray Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institute End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institute End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Academic & Research Institute End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gene Expression Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gene Expression Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Gene Expression Analysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Genotyping Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA Microarrays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION